SlideShare a Scribd company logo
Dr. Prerna Singh
Junior resident
Department of Pharmacology
JNMC, AMU
 Prevent fertility by interfering with reproductive mechanism
 Ideal contraceptive:
 100 % effective
 Safe
 Easy to use
 Reversible
 Affordable
 Appropriate to use at all stages of reproduction
Inhibition of ovulation
Prevent fertilization
Interfere with ova transport
Interfere with implantation
Distraction of early implanted embryo
Female
fertility
Anti
ovulatory
activity
HCG
induced
ovulation
Cupric
acetate
induced
ovulation
Estogenic
methods
In vivo
1.1.Vaginal
opening
2.Assay for
water uptake
3.Vaginal
cornification
4.Chick oviduct
method
In vitro
•1.Estrogenic
receptor
binding assay
•2.Potency
assay
Progestational
activity
In vivo
1.Pregnancy
maintenance
test
2.Proliferatio
n of uterine
endometrium
3.Carbonic
anhydrase
activity
4.Deciduoma
reaction
In vitro
Progesterone
receptor
binding assay
 Rationale: HCG induces follicular maturation and spontaneous
ovulation after 2 days
 Procedure: Immature female albino rats(24- 26 day)
 Immature rats do not ovulate spontaneously and do not show cyclical
change in vaginal epithelium
Albino rats: test drug in various dose
HCG
2 days later: rats sacrificed and ovaries
dissected.
Histopathology compared with control
 Rabbit - reflex ovulator
Ovulate few hours after mating
 mechanical stimulation of vagina
Presence of male
Female albino rabbit – 3-4 kg
Isolate rabbit for 21 days
Test drug
24 Hr later
1%Cupric acetate 0.3 ml/kg IV in
0.9% NS
Sacrifice after 24 hr
Number of ovulation points recorded
Histopathology of ovaries and uterus
Estrogen in immature albino rats(21 day old) – vaginal
opening occurs
Test and standard given IM in
cotton seed oil
Time of complete vaginal
opening observed
Estrogen- increase uptake and retention of water
Peak at 6 hr
Ovariectomized rat used
Test compound given in cotton seed oil SC
Sacrifice 5 hr after treatment
Excise uterus; weight; dry weight after drying
in oven at 100 degree for 24 hr; compare with
control
Estrus cycle: cascade of hormonal behavioral event and
highly synchronized and repetitive
Estrogenic drugs change animal to estrus stage
• Corpus lutea
• Progesterone
• Smear: leucocyte,
cornified cell
• 21 hr
• Corpus lutea regress
• Estrogen progesterone
regress
• Smear: leucocytes
• 57hr
• Uterus enlarged
extended – water
accumulation
• Estrogen peak
• Smear: squamous
cornified cell
• 12 hr
• Beginning
• Follicle start maturing
• Smear: nucleated epithelial
cell
• 12 hr
Pro-estrus Estrus
Met estrusDiestrus
Rats with regular estrus cycle are ovariectomized
Test and standard drug given In cotton seed oil oral
or SC for 4 days
Vaginal smear examined for cornified cell, leucocytes,
epithelial cell
Twice a day for 4 days
MODIFICATION: direct application of drug to vagina
7 day old chick
Inject test twice daily for 6 days SC
Sacrifice and weight of body and oviduct
compare ratio of oviduct weight to body weight of
control(0.02mcg- 0.5 mcg estradiol)
Estrogen - proliferation of oviduct in chicks
Estrogen along with antiestrogen given
Estrogen dose is that which is required to produce 50% of
maximum response
Water uptake, utero-trophy, cornification seen
In vitro:
Aromatase inhibition: Compound which inhibits aromatase
(estrogen synthase) possess anti- estorgenic activity
Ovariectomy done on 8th day of pregnancy
Standard and test drug are given for 13 days
along with estradiol
Rats killed on day 21
Average of Living fetus at end of experiment
counted
Prime with estradiol(0.5mcg/ml) daily
for 7 days
Test drug for 5 days
Sacrifice after 24 hours
Uteri dissected, histology done
 Linear relation between progesterone and carbonic anhydrase activity
Immature female albino rats
Primed with estradiol
Test and standard drug given
Sacrifice, uterus remove,
Evaluate carbonic anhydrase activity in
endometrial extract by calorimetry
 Principle: tumor formation by progesterone in ovariectomized rats
Ovariectomized rat primed with 1 mcg estradiol for 4
days
Test drug for 9 days
Day 5 – 1mg of histamine dihydrochloride injection in
lumen of uterine horn
Sacrifice
Horn cut off
Weight and histology compared
IV Oxytocin on day 30 of pregnancy – abortion
Prior progesterone – prevent it
Test drug
24 hr later 10U oxytocin IV day 30
Prevent abortion
Control will abort in 2- 30 min
PRINCIPLE: Competitive binding of labeled & unlabeled
progesterone on progesterone receptors.
 Progesterone competitively displace labeled progesterone in
a concentration dependent manner from progesterone
receptor
Albino rats in pre estrous or estrous phase
mated
Male: female= 1:3
Examine vaginal smear every morning for
spermatozoa
Day1 pregnancy – when sign of mating seen;
separate them then
Test drug
Day 10 of pregnancy- laparotomy done,
implants in uterus and uterine horn counted
number of corpus luteum
Complete pregnancy : count litter if any
 Pre implantation loss: number of CL on D10 – number of implantation on D10
 Post implantation loss: number of implant on D10 – number of litters delivered
 % Implantation loss:
𝑛𝑜.𝑜𝑓 𝐶𝐿 −𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡
𝑁𝑜.𝑜𝑓 𝐶𝐿
× 100
 %Post implantation loss
𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡 −𝑛𝑜.𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟𝑠
𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡
× 100
 % Antifertility activity
𝑛𝑜.𝑜𝑓 𝐶𝐿 −𝑛𝑜 𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟𝑠
𝑛𝑜.𝑜𝑓 𝐶𝐿
× 100
Confirm pregnancy by palpation after day 12
Intra amniotic and intra placental injection
under anesthesia on day 20
Effect: vaginal bleed
Weight change
Palpation
Interference with spermatogenesis without loss of libido &
secondary sexual characteristics
In vivo
1.Cohabitation
2.Fertility test
3.Subsidiary test
In vitro
1.Spermicidal activity
2.Immobilization assay
3. Non specific
aggregation estimation
Male female in 2:1 ratio kept for mating
Till both female deliver
Date of mating – from date of parturition
Time interval for litter production after placing
treated males with 2 females is calculated
 Anti-fertility agents negatively affect average litter size
Male female paired in 1:3 ratio
Vaginal smear daily – for presence of
sperm
Mated animal kept separately
Average litter size =
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟
𝑛𝑜.𝑜𝑓 𝑓𝑒𝑚𝑎𝑙𝑒𝑠 𝑚𝑎𝑡𝑒𝑑
Determine changes in spermatozoa count with drug
Rats kept in cage with artificial or
animal vagina
Ejaculates diluted with saline
containing traces of formalin
Suspension counted on
hemocytometer
Spermicidal drugs diluted in saline & serial
dilkution made in 0.2 ml of human seminal fluid
with 1ml of spermicidal sol.
Mixture incubated at 37oC for 30 min
A drop placed on slide & at least 5 fields were
observed under 400X for assessment of sperm
morphological change & motility
Human sample from 10 normal subjects after 72-96
hrs. of sexual abstinence subjected to routine semen
analysis count >100 million/ml & viability > 60% taken
for test
mixed in 1:1 ratio with different conc. of drugs
drop of mixture placed on a slide & at least 5 field
were microscopically observed under 400X for
assessment of motility.
Diff. conc. of drug mixed with ram sperm
suspension in1:1 ratio & kept at 37oC for 1 hr
Then from bottom of centrifuge tube, one
drop of sediment sperm placed on a slide &
% aggregation examined under 400X
the non-aggregated spermatozoa will remain
in supernatant, it collected & turbidity
determined spectrophotometrically at 545nm
Aggregation is indirectly proportional to sperm viability.
 1.CHICKEN COMB METHOD
PRINCIPLE: Growth of cap on comb by androgenic compounds
PROCEDURE:
 Sum of length plus height of each comb determined with mm ruler
 Capons inj. daily IM for 5 days with solution of test & standard drug in
1ml olive oil
 24 hrs after last inj. comb re-measured
 Compared statistically
PRINCIPLE: Androgen affect secondary sexual characters
PROCEDURE:
 Orchidectomy of Immature male rats of weight 50gm done
 Animals treated with test drug in different doses in 0.2 ml sesame oil
daily for 10 days
 In standard methyl testosterone given SC in 0.25, 1.5, 5 mg per
animals
 Control given vehicle only
 On 11th day animals scarified & seminal vesicles, ventral prostrate &
musculus levator ani dissected & weight & compared
. CHICKEN COMB METHOD
PRINCIPLE: Inhibition of growth of capon by anti-androgenic comp.
PROCEDURE:
 1-3 day old male white Leghorn chicks used
 Feed from day 1 on testosterone mixed in finely ground chick starting
mash at conc. of 80mg/kg food
 Test comp. dissolved in sesame oil & 0.1 ml inj sc daily for 4 day
 Control chicks receive only vehicle
 24 hr after last inj. Animals scarified & comb removed & weighed rapidly
& compare
2. ANTAGONISM OF EFFECT OF TESTOSTERONE ON
WEIGHT OF VENTRAL PROSTARTE, SEMINAL
VESICLE & MUSCULUS LEVATOR ANI
PROCEDURE:
Same as for androgenic activity with addition of test drug
given simultaneously SC dissolved in sesame oil at a
separate site for 7 days.
S.K. Gupta Drug screening methods
H. Gerhard Vogel (Ed.) Drug Discovery and
Evaluation
Antifertility screening

More Related Content

What's hot

Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
Jaineel Dharod
 
Pre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugsPre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugs
Aaqib Naseer
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
Rashmi116
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Behavior and muscle coordination
Behavior and muscle coordinationBehavior and muscle coordination
Behavior and muscle coordination
Bhupen Singh
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
Dr. Manu Kumar Shetty
 
Screening models of alzheimer’s disease
Screening models of alzheimer’s disease Screening models of alzheimer’s disease
Screening models of alzheimer’s disease
VishnuPrabhakar26
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
Jaineel Dharod
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
Jitendra Agrawal
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
VikasMalik68
 
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
Shubham Kolge
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
DHINESHKUMAR V
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolyticsSayanti Sau
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
pradnya Jagtap
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
Afreen Hashmi
 
screening model for parkinsons disease
screening model for parkinsons diseasescreening model for parkinsons disease
screening model for parkinsons disease
Kundlik Rathod
 

What's hot (20)

Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
screening of anti-fertility agent
screening of anti-fertility agentscreening of anti-fertility agent
screening of anti-fertility agent
 
Pre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugsPre clinical screening of anti fertility drugs
Pre clinical screening of anti fertility drugs
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Behavior and muscle coordination
Behavior and muscle coordinationBehavior and muscle coordination
Behavior and muscle coordination
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Screening models of alzheimer’s disease
Screening models of alzheimer’s disease Screening models of alzheimer’s disease
Screening models of alzheimer’s disease
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
 
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer Drugs
 
Preclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic DrugsPreclinical Screening of Antiasthmatic Drugs
Preclinical Screening of Antiasthmatic Drugs
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
Screening models of Anti diabetics.
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
 
Screening Methods for behavioural and muscle Coordination
 Screening Methods for behavioural and muscle Coordination Screening Methods for behavioural and muscle Coordination
Screening Methods for behavioural and muscle Coordination
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
 
screening model for parkinsons disease
screening model for parkinsons diseasescreening model for parkinsons disease
screening model for parkinsons disease
 

Similar to Antifertility screening

Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agents
Akanksha William
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointt
sujitha12341
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkesha
kahkesha samshad
 
Fertility and antifertility screening
Fertility and antifertility screeningFertility and antifertility screening
Fertility and antifertility screening
nazuk sharma
 
Ppt on antifertility
Ppt on antifertilityPpt on antifertility
Ppt on antifertility
Mr. MOHD FAHAD
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptx
Praveen kumar S
 
In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activity
swapniltirmanwar
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
Aanchal46
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
Khadga Raj
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
Khadga Raj
 
Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
Loveinder Bhardwaj
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
SONALPANDE5
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUE
Tripti Sidar
 
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptxREPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
manishaJyala2
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
VISHALJADHAV100
 
thesis seminar
 thesis seminar thesis seminar
thesis seminar
Aashish Tanwar
 
DOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptxDOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptx
SiddharthShekharSing4
 
seminario biologia molecular
seminario biologia molecular seminario biologia molecular
seminario biologia molecular
juan jose gonzalez arias
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
ashharnomani
 
AAZ Conference Poster Oct 2014
AAZ Conference Poster Oct 2014AAZ Conference Poster Oct 2014
AAZ Conference Poster Oct 2014Hall Emily
 

Similar to Antifertility screening (20)

Experimental evaluation of antifertility agents
Experimental evaluation of antifertility agentsExperimental evaluation of antifertility agents
Experimental evaluation of antifertility agents
 
Screening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointtScreening of anti-fertility agents.powerpointt
Screening of anti-fertility agents.powerpointt
 
Preclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkeshaPreclinical screening of antifertility agents. kahkesha
Preclinical screening of antifertility agents. kahkesha
 
Fertility and antifertility screening
Fertility and antifertility screeningFertility and antifertility screening
Fertility and antifertility screening
 
Ppt on antifertility
Ppt on antifertilityPpt on antifertility
Ppt on antifertility
 
screening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptxscreening of reproductive pharmacology .pptx
screening of reproductive pharmacology .pptx
 
In vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activityIn vivo evaluation techniques, for Antifertility agent/activity
In vivo evaluation techniques, for Antifertility agent/activity
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
Reproductive toxicology
Reproductive toxicologyReproductive toxicology
Reproductive toxicology
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Reproductive toxicity studies
Reproductive toxicity studiesReproductive toxicity studies
Reproductive toxicity studies
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
ARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUEARTIFICIAL REPRODUCTIVE TECHNIQUE
ARTIFICIAL REPRODUCTIVE TECHNIQUE
 
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptxREPRODUCTIVE TOXICITY  STUDIE OF MALE AND FEMALEpptx
REPRODUCTIVE TOXICITY STUDIE OF MALE AND FEMALEpptx
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
 
thesis seminar
 thesis seminar thesis seminar
thesis seminar
 
DOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptxDOC-20220404-WA0001..pptx
DOC-20220404-WA0001..pptx
 
seminario biologia molecular
seminario biologia molecular seminario biologia molecular
seminario biologia molecular
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
AAZ Conference Poster Oct 2014
AAZ Conference Poster Oct 2014AAZ Conference Poster Oct 2014
AAZ Conference Poster Oct 2014
 

More from Prerna Singh

Neurocysticercosis
NeurocysticercosisNeurocysticercosis
Neurocysticercosis
Prerna Singh
 
Renal physiological function
Renal physiological functionRenal physiological function
Renal physiological function
Prerna Singh
 
Newer antidiabetic agents
Newer antidiabetic agentsNewer antidiabetic agents
Newer antidiabetic agents
Prerna Singh
 
ANTI OBESITY
ANTI OBESITY  ANTI OBESITY
ANTI OBESITY
Prerna Singh
 
Pharmaeconomics
Pharmaeconomics Pharmaeconomics
Pharmaeconomics
Prerna Singh
 
Drugs affecting renal excretory function
Drugs affecting renal excretory functionDrugs affecting renal excretory function
Drugs affecting renal excretory function
Prerna Singh
 
Alpha blocker
Alpha blockerAlpha blocker
Alpha blocker
Prerna Singh
 
Parkinson pharmacotherapy
Parkinson pharmacotherapy Parkinson pharmacotherapy
Parkinson pharmacotherapy
Prerna Singh
 
Asthma pharmacotherapy
Asthma pharmacotherapyAsthma pharmacotherapy
Asthma pharmacotherapy
Prerna Singh
 
Malaria
MalariaMalaria
Malaria
Prerna Singh
 
Type 2 diabetes
Type 2 diabetesType 2 diabetes
Type 2 diabetes
Prerna Singh
 
Seizure
SeizureSeizure
Seizure
Prerna Singh
 
Memb transporter
Memb transporterMemb transporter
Memb transporter
Prerna Singh
 

More from Prerna Singh (14)

Neurocysticercosis
NeurocysticercosisNeurocysticercosis
Neurocysticercosis
 
Renal physiological function
Renal physiological functionRenal physiological function
Renal physiological function
 
Newer antidiabetic agents
Newer antidiabetic agentsNewer antidiabetic agents
Newer antidiabetic agents
 
ANTI OBESITY
ANTI OBESITY  ANTI OBESITY
ANTI OBESITY
 
Pharmaeconomics
Pharmaeconomics Pharmaeconomics
Pharmaeconomics
 
Pg analogue
Pg analoguePg analogue
Pg analogue
 
Drugs affecting renal excretory function
Drugs affecting renal excretory functionDrugs affecting renal excretory function
Drugs affecting renal excretory function
 
Alpha blocker
Alpha blockerAlpha blocker
Alpha blocker
 
Parkinson pharmacotherapy
Parkinson pharmacotherapy Parkinson pharmacotherapy
Parkinson pharmacotherapy
 
Asthma pharmacotherapy
Asthma pharmacotherapyAsthma pharmacotherapy
Asthma pharmacotherapy
 
Malaria
MalariaMalaria
Malaria
 
Type 2 diabetes
Type 2 diabetesType 2 diabetes
Type 2 diabetes
 
Seizure
SeizureSeizure
Seizure
 
Memb transporter
Memb transporterMemb transporter
Memb transporter
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 

Antifertility screening

  • 1. Dr. Prerna Singh Junior resident Department of Pharmacology JNMC, AMU
  • 2.  Prevent fertility by interfering with reproductive mechanism  Ideal contraceptive:  100 % effective  Safe  Easy to use  Reversible  Affordable  Appropriate to use at all stages of reproduction
  • 3. Inhibition of ovulation Prevent fertilization Interfere with ova transport Interfere with implantation Distraction of early implanted embryo
  • 4. Female fertility Anti ovulatory activity HCG induced ovulation Cupric acetate induced ovulation Estogenic methods In vivo 1.1.Vaginal opening 2.Assay for water uptake 3.Vaginal cornification 4.Chick oviduct method In vitro •1.Estrogenic receptor binding assay •2.Potency assay Progestational activity In vivo 1.Pregnancy maintenance test 2.Proliferatio n of uterine endometrium 3.Carbonic anhydrase activity 4.Deciduoma reaction In vitro Progesterone receptor binding assay
  • 5.  Rationale: HCG induces follicular maturation and spontaneous ovulation after 2 days  Procedure: Immature female albino rats(24- 26 day)  Immature rats do not ovulate spontaneously and do not show cyclical change in vaginal epithelium
  • 6. Albino rats: test drug in various dose HCG 2 days later: rats sacrificed and ovaries dissected. Histopathology compared with control
  • 7.  Rabbit - reflex ovulator Ovulate few hours after mating  mechanical stimulation of vagina Presence of male Female albino rabbit – 3-4 kg
  • 8. Isolate rabbit for 21 days Test drug 24 Hr later 1%Cupric acetate 0.3 ml/kg IV in 0.9% NS Sacrifice after 24 hr Number of ovulation points recorded Histopathology of ovaries and uterus
  • 9.
  • 10. Estrogen in immature albino rats(21 day old) – vaginal opening occurs Test and standard given IM in cotton seed oil Time of complete vaginal opening observed
  • 11. Estrogen- increase uptake and retention of water Peak at 6 hr Ovariectomized rat used Test compound given in cotton seed oil SC Sacrifice 5 hr after treatment Excise uterus; weight; dry weight after drying in oven at 100 degree for 24 hr; compare with control
  • 12. Estrus cycle: cascade of hormonal behavioral event and highly synchronized and repetitive Estrogenic drugs change animal to estrus stage
  • 13. • Corpus lutea • Progesterone • Smear: leucocyte, cornified cell • 21 hr • Corpus lutea regress • Estrogen progesterone regress • Smear: leucocytes • 57hr • Uterus enlarged extended – water accumulation • Estrogen peak • Smear: squamous cornified cell • 12 hr • Beginning • Follicle start maturing • Smear: nucleated epithelial cell • 12 hr Pro-estrus Estrus Met estrusDiestrus
  • 14.
  • 15. Rats with regular estrus cycle are ovariectomized Test and standard drug given In cotton seed oil oral or SC for 4 days Vaginal smear examined for cornified cell, leucocytes, epithelial cell Twice a day for 4 days MODIFICATION: direct application of drug to vagina
  • 16. 7 day old chick Inject test twice daily for 6 days SC Sacrifice and weight of body and oviduct compare ratio of oviduct weight to body weight of control(0.02mcg- 0.5 mcg estradiol) Estrogen - proliferation of oviduct in chicks
  • 17. Estrogen along with antiestrogen given Estrogen dose is that which is required to produce 50% of maximum response Water uptake, utero-trophy, cornification seen In vitro: Aromatase inhibition: Compound which inhibits aromatase (estrogen synthase) possess anti- estorgenic activity
  • 18.
  • 19. Ovariectomy done on 8th day of pregnancy Standard and test drug are given for 13 days along with estradiol Rats killed on day 21 Average of Living fetus at end of experiment counted
  • 20. Prime with estradiol(0.5mcg/ml) daily for 7 days Test drug for 5 days Sacrifice after 24 hours Uteri dissected, histology done
  • 21.  Linear relation between progesterone and carbonic anhydrase activity Immature female albino rats Primed with estradiol Test and standard drug given Sacrifice, uterus remove, Evaluate carbonic anhydrase activity in endometrial extract by calorimetry
  • 22.  Principle: tumor formation by progesterone in ovariectomized rats Ovariectomized rat primed with 1 mcg estradiol for 4 days Test drug for 9 days Day 5 – 1mg of histamine dihydrochloride injection in lumen of uterine horn Sacrifice Horn cut off Weight and histology compared
  • 23. IV Oxytocin on day 30 of pregnancy – abortion Prior progesterone – prevent it Test drug 24 hr later 10U oxytocin IV day 30 Prevent abortion Control will abort in 2- 30 min
  • 24. PRINCIPLE: Competitive binding of labeled & unlabeled progesterone on progesterone receptors.  Progesterone competitively displace labeled progesterone in a concentration dependent manner from progesterone receptor
  • 25. Albino rats in pre estrous or estrous phase mated Male: female= 1:3 Examine vaginal smear every morning for spermatozoa Day1 pregnancy – when sign of mating seen; separate them then Test drug Day 10 of pregnancy- laparotomy done, implants in uterus and uterine horn counted number of corpus luteum Complete pregnancy : count litter if any
  • 26.  Pre implantation loss: number of CL on D10 – number of implantation on D10  Post implantation loss: number of implant on D10 – number of litters delivered  % Implantation loss: 𝑛𝑜.𝑜𝑓 𝐶𝐿 −𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡 𝑁𝑜.𝑜𝑓 𝐶𝐿 × 100  %Post implantation loss 𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡 −𝑛𝑜.𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟𝑠 𝑛𝑜.𝑜𝑓 𝑖𝑚𝑝𝑙𝑎𝑛𝑡 × 100  % Antifertility activity 𝑛𝑜.𝑜𝑓 𝐶𝐿 −𝑛𝑜 𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟𝑠 𝑛𝑜.𝑜𝑓 𝐶𝐿 × 100
  • 27. Confirm pregnancy by palpation after day 12 Intra amniotic and intra placental injection under anesthesia on day 20 Effect: vaginal bleed Weight change Palpation
  • 28. Interference with spermatogenesis without loss of libido & secondary sexual characteristics In vivo 1.Cohabitation 2.Fertility test 3.Subsidiary test In vitro 1.Spermicidal activity 2.Immobilization assay 3. Non specific aggregation estimation
  • 29. Male female in 2:1 ratio kept for mating Till both female deliver Date of mating – from date of parturition Time interval for litter production after placing treated males with 2 females is calculated
  • 30.  Anti-fertility agents negatively affect average litter size Male female paired in 1:3 ratio Vaginal smear daily – for presence of sperm Mated animal kept separately Average litter size = 𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑡𝑡𝑒𝑟 𝑛𝑜.𝑜𝑓 𝑓𝑒𝑚𝑎𝑙𝑒𝑠 𝑚𝑎𝑡𝑒𝑑
  • 31. Determine changes in spermatozoa count with drug Rats kept in cage with artificial or animal vagina Ejaculates diluted with saline containing traces of formalin Suspension counted on hemocytometer
  • 32. Spermicidal drugs diluted in saline & serial dilkution made in 0.2 ml of human seminal fluid with 1ml of spermicidal sol. Mixture incubated at 37oC for 30 min A drop placed on slide & at least 5 fields were observed under 400X for assessment of sperm morphological change & motility
  • 33. Human sample from 10 normal subjects after 72-96 hrs. of sexual abstinence subjected to routine semen analysis count >100 million/ml & viability > 60% taken for test mixed in 1:1 ratio with different conc. of drugs drop of mixture placed on a slide & at least 5 field were microscopically observed under 400X for assessment of motility.
  • 34. Diff. conc. of drug mixed with ram sperm suspension in1:1 ratio & kept at 37oC for 1 hr Then from bottom of centrifuge tube, one drop of sediment sperm placed on a slide & % aggregation examined under 400X the non-aggregated spermatozoa will remain in supernatant, it collected & turbidity determined spectrophotometrically at 545nm Aggregation is indirectly proportional to sperm viability.
  • 35.  1.CHICKEN COMB METHOD PRINCIPLE: Growth of cap on comb by androgenic compounds PROCEDURE:  Sum of length plus height of each comb determined with mm ruler  Capons inj. daily IM for 5 days with solution of test & standard drug in 1ml olive oil  24 hrs after last inj. comb re-measured  Compared statistically
  • 36. PRINCIPLE: Androgen affect secondary sexual characters PROCEDURE:  Orchidectomy of Immature male rats of weight 50gm done  Animals treated with test drug in different doses in 0.2 ml sesame oil daily for 10 days  In standard methyl testosterone given SC in 0.25, 1.5, 5 mg per animals  Control given vehicle only  On 11th day animals scarified & seminal vesicles, ventral prostrate & musculus levator ani dissected & weight & compared
  • 37. . CHICKEN COMB METHOD PRINCIPLE: Inhibition of growth of capon by anti-androgenic comp. PROCEDURE:  1-3 day old male white Leghorn chicks used  Feed from day 1 on testosterone mixed in finely ground chick starting mash at conc. of 80mg/kg food  Test comp. dissolved in sesame oil & 0.1 ml inj sc daily for 4 day  Control chicks receive only vehicle  24 hr after last inj. Animals scarified & comb removed & weighed rapidly & compare
  • 38. 2. ANTAGONISM OF EFFECT OF TESTOSTERONE ON WEIGHT OF VENTRAL PROSTARTE, SEMINAL VESICLE & MUSCULUS LEVATOR ANI PROCEDURE: Same as for androgenic activity with addition of test drug given simultaneously SC dissolved in sesame oil at a separate site for 7 days.
  • 39. S.K. Gupta Drug screening methods H. Gerhard Vogel (Ed.) Drug Discovery and Evaluation

Editor's Notes

  1. Excess estrogen inhbit lh fsh prevent ovulation
  2. Normal pregnant rats have an average of 11 implanta- tion sites and about 10 live embryos.
  3. PRINCIPLE: Female rabbits primed with estradiol & followed by adm. of progestational comp. lead to proliferation of endometrium & converted into secretary phase.
  4. Drug having Progestational activity prevent abortion